Clinical features, prognostic and risk factors of central nervous system infections in patients with systemic lupus erythematosus

Clinical Rheumatology

Volumn 26, Issue 6, 2007, Pages 895-901

  Yang, Cheng De ^a   Wang, Xiao Dong ^a   Ye, Shuang ^a   Gu, Yue Ying ^a   Bao, Chun De ^a   Wang, Yuan ^a   Chen, Shun Le ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Central nervous system; Infection; SLE

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; AZATHIOPRINE; CEPHALOSPORIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIAL INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DRUG MEGADOSE; FEMALE; GRAM POSITIVE BACTERIUM; HUMAN; KLEBSIELLA PNEUMONIAE; LISTERIA MONOCYTOGENES; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; MYCOBACTERIUM TUBERCULOSIS; MYCOSIS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; TUBERCULOSIS;

ADOLESCENT; ADULT; CENTRAL NERVOUS SYSTEM INFECTIONS; CHINA; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PREDNISOLONE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX;

EID: 34250755581     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0424-x     Document Type: Article

References (34)

1. Iliopoulos AG, Tsokos GC (1996) Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Seminars Arthritis Rheum 25:318-336
2. Staples PJ, Gerding DN, Decker JL, Gordon RS Jr (1974) Incidence of infection in systemic lupus erythematosus. Arthritis Rheim 17:1-10
3. Boumpas DT, Paliogianni F, Anastassiou ED, Balow JE (1991) Gluococorticosteroid action on the immune system: Molecular and cellular aspects. Clin Exp Rheumatol 9:413-423
4. Duffy KN, Duffy CM, Gladman DD (1991) Infection and disease activity in systemic lupus erythematosus: A review of hospitalized patients. J Rheumatol 18:1180-1184
5. Ward MM, Pyun E, Studenski S (1995) Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort. Arthritis Rheum 38:1492-1499
6. Ward MM, Pyun E, Studenski S (1995) Long-term survival in systemic lupus erythematosus: Patient characteristics associated with poorer outcomes. Arthritis Rheum 38:274-283
7. Petri M, Genovese M (1992) Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: A prospective study of the Hopkins Lupus Cohort. J Rheumatol 19:1559-1565
8. Zonana-Nacach A, Camargo-Coronel A, Yanez P, Sanchez L, Jimenez-Balderas FJ, Fraga A (2001) Infections in outpatients with systemic lupus erythematosus: A prospective study. Lupus 10:505-510
9. Kraus A, Cabral AR, Sifuentes-Osornio J, Alarcon-Segovia D (1994) Listeriosis in patients with connective tissue disease. J Rheumatol 21:635-638
10. Liou J, Chiu C, Tseng C, Chi C, Fu L (2003) Cryptococcal meningitis in pediatric systemic lupus erythematosus. Mycoses 46:153-156
11. Mok CC, Lau CS, Yuen KY (1998) Cryptococcal meningitis presenting concurrently with systemic lupus erythematosus. Clin Exp Rheumatol 16:169-171
12. Hung JJ, Ou LS, Lee W, Huang JL (2005) Central nervous system infections in patients with systemic lupus erythematosus. J Rheumatol 32:40-43
13. Tam LS, Li EK, Wong SM, Szeto CC (2002) Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong. Scand J Rheumatol 31:296-300
14. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
15. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630-640
16. Jennett B, Bond M (1975) Assessment of outcome after severe brain damage. A practical scale. Lancet 1:480-484
17. Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL et al (1997) Bacterial meningitis in the United States in 1995. Active surveillance team. N Engl J Med 337:970-976
18. Sigurdardottir B, Bjornsson OM, Jonsdottir KE, Erlendsdottir H, Gudmundsson S (1997) Acute bacterial meningitis in adults. A 20-year overview. Arch Intern Med 24:425-430
19. Beek DVD, Gans JD, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M (2004) Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 351:1849-1859
20. Young LS (1993) Mycobacterial diseases and the compromised host. Clin Infect Dis 17(suppl 2):436-441
21. Feng PH, Tan TH (1982) Tuberculosis in patients with systemic lupus erythematosus. Ann Rheum Dis 41:11-14
22. Hui ACF, Ngb KC, Tonga PY, Moka V, Chowa KM, Wua A, Wonga LKS (2005) Bacterial meningitis in Hong Kong: 10-years' experience. Clin Neurol Neuro 107:366-370
23. Skogberg K, Ruutu P, Tukiainen P, Valtonen V (1993) Effect of immunosuppressive therapy on the clinical presentation and outcome of tuberculosis. Clin Infect Dis 17:1012-1017
24. Stecher DR, Gusis S, Maldonado Cocco JA (1992) Tuberculous arthritis in the course of connective tissue disease: Report of 4 cases. J Rheumatol 19:1418-1420
25. Gladman DD, Hussain F, Ibanez D, Urowitz MB (2002) The nature and outcome of infection in systemic lupus erythematosus. Lupus 11:234-239
26. Zonana-Nacach A, Camargo-Coronel A, Yanez P, Sanchez L, Jimenez-Balderas FJ, Fraga A (2001) Infections in outpatients with systemic lupus erythematosus: A prospective study. Lupus 10:505-510
27. Yuhara T, Takemura H, Akama T, Suzuki H, Yamane K, Kashiwagi H (1996) Predicting infection in hospitalized patients with systemic lupus erythematosus. Intern Med 35:629-636
28. Pryor BD, Bologna SG, Kahl LE (1996) Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 39:1475-1482
29. Cohen J, Pinching AJ, Rees AJ, Peters DK (1982) Infection and immunosuppression. A study of the infective complications of 75 patients with immunologically-mediated disease. Q J Med 201:1-15
30. Ginzler E, Diamond H, Kaplan D, Weiner M, Schlesinger M, Seleznick M (1978) Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum 21:37-44
31. ter Borg EJ, Horst G, Limburg PC, van Rijswijk MH, Kallenberg CG (1990) C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: A prospective longitudinal study. J Rheumatol 17:1642-1648
32. Caldwell JR, Furst DE (1991) The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis. Semin Arthritis Rheum 21:1-11
33. Carmona L, Gomez-Reino JJ, Rodriguez-Valverde V, Montero D, Pascual-Gomez E, Mola EM et al (2005) Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 52:1766-1772
34. Bresnihan B, Cunnane G (2003) Infection complications associated with the use of biologic agents. Rheum Dis Clin North Am 29:185-202